About Robert Poole
Form D filings for Lucy Therapeutics in 2024 list Robert Poole as director.
Robert Poole first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Poole in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Poole works with at each company, as listed on that company's latest Form D.
Lucy Therapeutics, Inc. · Form D/A, May 2, 2024